Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    mental health

    Delusional disorder

    Also known as: Persistent delusional disorder, Paranoid disorder, Delusional psychosis

    Delusional disorder is characterised by persistent, fixed, idiosyncratic beliefs that remain refractory to contradictory evidence. While global functioning and behaviour may remain relatively preserved outside the delusional domain, differential diagnosis must exclude schizophrenia, mood disorders with psychotic features, substance-induced psychosis, delirium, and primary neurological pathologies. Primary management necessitates psychiatric intervention, psychological support, and pharmacotherapy. TCM pattern differentiation serves as an adjunctive approach for associated distress, sleep cycle disturbances, or somatic manifestations; it does not facilitate diagnosis or substantiate delusional ideation. Current research regarding herbal adjuncts in schizophrenia reports low-certainty findings and cannot be extrapolated to establish efficacy for delusional disorder. Evidence derived from cardiac-neurosis research is indirect and of substandard quality, while cited anxiety-insomnia studies are protocols lacking outcome data. No identified studies establish acupuncture efficacy for this condition, and included oncology pharmacovigilance reports do not inform clinical treatment.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain consistent circadian rhythms and monitor sleep duration without compensatory checking behaviours.
    • •Adhere to regular nutritional intake, ensure adequate hydration, and engage in gentle diurnal physical activity calibrated to current energy reserves.
    • •Abstain from cannabis and stimulants; maintain transparent communication with the clinical team regarding alcohol or substance use.
    • •With consent, involve a trusted support person in a written care and crisis plan; support persons should respond to distress without debating or endorsing delusional beliefs.

    Cautions & Contraindications

    See sources
    • •Do not reduce or cease antipsychotics on the basis of the adjunctive herbal review, including its low-dose comparisons. Prescribing decisions remain with the treating clinician; evidence is low certainty and not specific to delusional disorder.[]
    • •Do not initiate herbs before medication reconciliation and pharmacist review, especially with QT-prolonging drugs, anticoagulants or sedatives. Aggregate adverse-event findings in source 1 do not establish the safety of these individual combinations; the interaction precautions are not directly tested there.[]
    • •Defer needling when informed consent cannot be obtained, agitation prevents safe stillness, or needles are incorporated into persecutory beliefs. Never coerce treatment. This is a clinical safety precaution, not a finding established by the anxiety-insomnia trial protocol.[]

    When to reassess or seek care again

    See sources

    Establish baseline sleep duration, insomnia severity, distress on a 0–10 scale, daily functioning, adherence and adverse effects. Review tolerability and safety within 1–2 weeks and adjunctive goals at 4 weeks with the mental health team. Stop or revise adjunctive care if there is no meaningful benefit, worsening mistrust or adverse effects. Escalating delusional preoccupation, functional decline or missed essential treatment warrants prompt psychiatric review; acute risk warrants immediate escalation.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Schizophrenia (Heidelberg, Germany) · 2026
    2. Frontiers in psychiatry · 2024
    3. Frontiers in psychiatry · 2025
    4. Frontiers in pharmacology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.